Home Search
medicare drug price - search results
If you're not happy with the results, please do another search
Lawsuits Challenge Medicare Drug Price Controls
Drug makers Merck and Bristol Myers Squibb (BMS), and the U.S. Chamber of Commerce have filed separate lawsuits challenging Medicare’s new authority to negotiate...
Medicare Prescription Drug Price Controls Come with Strings Attached
The IRA’s supporters point to the savings to seniors resulting from the new law’s Medicare provisions, but many of these won’t take effect for years and will come with trade-offs.
Sudy: Medicare Price Control Bill Would Lead to Fewer Cutting Edge Drugs
Though the words “price controls” appear nowhere in the latest compromise framework, the mandatory negotiations and accompanying tax penalties are price controls in all but name.
Analysis of the 2024 Medicare Trustees’ Report
Analysis of the 2024 Medicare Trustees' Report shows the Hospital Trust Fund will reach insolvency in 2036, says CRFB.
by Committee for a Responsible Federal...
Small Firms Introduce More Drugs at Lower Costs—Report
Drug price controls in the Inflation Reduction Act (IRA) will not stymie the introduction of new products, because innovative drugs are increasingly being developed...
Legislation Aims to Protect Drug Research for Rare Diseases
U.S. House members introduced bipartisan legislation to reverse sanctions on small-molecule medicines in early February, providing new hope for people with rare diseases.
Proposed by...
To Save Medicare, Build on What Works – Commentary
By Joe Albanese
(From the Washington Examiner) Politicians usually avoid proposing changes to Medicare in an election year, but the program’s rising costs and expected insolvency within the next five...
Congress Mulls Tackling Abuses of 340B Drug Discount Program
A bipartisan group of U.S. Senators is seeking feedback on a controversial program that requires drug makers to sell discounted drugs to hospitals and...
Americans Born Today Will Use Prescription Drugs for Half Their Lives–Study
Americans are taking prescription drugs over longer periods of their lives, and the trend is raising new questions about the costs’ impact on the...
Price Transparency Is a Fraud in a Fake Market – Commentary
By Deane Waldman, M.D.
A recent report by the group Patient Rights Advocate (PRA) claims health care price transparency could save as much as $1 trillion a...